LC
MDT icon

Lindbrook Capital’s Medtronic MDT Stock Holding History

Lindbrook Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$946K Buy
10,533
+2,739
+35% +$245K 0.09% 137
2024
Q4 		$623K Sell
7,794
-176
-2% -$15.2K 0.06% 190
2024
Q3 		$718K Sell
7,970
-239
-3% -$20.1K 0.06% 174
2024
Q2 		$646K Sell
8,209
-197
-2% -$16.1K 0.06% 173
2024
Q1 		$733K Buy
8,406
+150
+2% +$12.8K 0.07% 164
2023
Q4 		$680K Buy
8,256
+1,216
+17% +$92.7K 0.07% 159
2023
Q3 		$552K Sell
7,040
-1,292
-16% -$108K 0.06% 170
2023
Q2 		$734K Buy
8,332
+1,825
+28% +$157K 0.08% 148
2023
Q1 		$525K Buy
6,507
+826
+15% +$67.3K 0.06% 165
2022
Q4 		$442K Sell
5,681
-530
-9% -$43K 0.05% 199
2022
Q3 		$502K Buy
6,211
+141
+2% +$12.7K 0.08% 139
2022
Q2 		$545K Sell
6,070
-888
-13% -$90K 0.09% 136
2022
Q1 		$772K Sell
6,958
-665
-9% -$70.3K 0.12% 111
2021
Q4 		$789K Buy
7,623
+2,319
+44% +$269K 0.12% 103
2021
Q3 		$665K Buy
5,304
+41
+0.8% +$5.31K 0.17% 48
2021
Q2 		$653K Buy
5,263
+17
+0.3% +$2.13K 0.15% 56
2021
Q1 		$620K Buy
5,246
+118
+2% +$13.8K 0.14% 56
2020
Q4 		$601K Buy
5,128
+7
+0.1% +$771 0.15% 54
2020
Q3 		$532K Buy
5,121
+285
+6% +$28.6K 0.15% 53
2020
Q2 		$443K Buy
4,836
+443
+10% +$42.5K 0.13% 59
2020
Q1 		$396K Sell
4,393
-1,050
-19% -$112K 0.15% 56
2019
Q4 		$618K Buy
5,443
+43
+0.8% +$4.72K 0.22% 43
2019
Q3 		$587K Buy
5,400
+14
+0.3% +$1.46K 0.22% 41
2019
Q2 		$524K Buy
5,386
+41
+0.8% +$3.74K 0.2% 48
2019
Q1 		$486K Sell
5,345
-216
-4% -$19.3K 0.19% 50
2018
Q4 		$505K Buy
+5,561
New +$520K 0.25% 40

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lindbrook Capital's MDT Position: Q1 2025 in Review

Lindbrook Capital increased its Medtronic (MDT) stake by 35% in Q1 2025, buying an estimated $245K and bringing the position to 10,533 shares worth $946K. The position accounts for 0.09% of the portfolio, ranked #137.

Lindbrook Capital first reported a position in MDT in Q4 2018 and has held it in 26 quarters since. 2,172 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Lindbrook Capital held 10,533 shares of Medtronic worth $946K as of Q1 2025.
  • Lindbrook Capital bought 2,739 Medtronic shares in Q1 2025, an estimated $245K.
  • Medtronic made up 0.09% of Lindbrook Capital's portfolio in Q1 2025, its #137 holding.
  • Lindbrook Capital first reported a position in Medtronic in Q4 2018 and has held it in 26 quarters since.
  • 2,172 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.